š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to evaluate the safety and effectiveness of AC...
Status
Completed
Location
Radiant Research
Start Date
2005-11
Trial ID
NCT00249782
To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment...
Status
Completed
Location
Dermatology and Laser Surgery
Start Date
2016-10
Trial ID
NCT02944461
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics (PK) an...
Status
Completed
Location
Kirklin Clinic
Start Date
2016-10-31
Trial ID
NCT02959970
Treatments Being Tested
This study will assess the safety and efficacy of dapsone gel versus vehicl...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01974323
Treatments Being Tested
A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00835198
Treatments Being Tested
A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00834210
Treatments Being Tested
This study will evaluate the potential of dapsone gel and its vehicle to ca...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02117739
Treatments Being Tested
This study will assess the safety, tolerability, and efficacy of dapsone in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01785836
Treatments Being Tested
Acne vulgaris, a chronic inļ¬ammatory skin disorder, is one of the most prev...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT05296460
Treatments Being Tested
Acne vulgaris (AV) is a disease of the pilosebaceous unit that causes nonin...
Status
Completed
Location
JPMC
Start Date
2022-08-01
Trial ID
NCT05926869
Treatments Being Tested